When [⁶⁸Ga]Ga-PSMA and [¹⁸F]F-FDG PET/CT Fail: [⁶⁸Ga]Ga-FAPI PET/CT in a Case of PSA-Progressive Prostate Cancer
- 30 May 2026
- journal article
- Published by Springer Nature in Nuclear Medicine and Molecular Imaging
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Characterizing PSMA heterogeneity in prostate cancer and identifying clinically actionable tumor associated antigens in PSMA negative casesScientific Reports, 2025
- Contribution of 68Ga-DOTA-FAPI-04 PET/CT to Prostate Cancer ImagingClinical Nuclear Medicine, 2024
- Hetero-bivalent agents targeting FAP and PSMAEuropean Journal of Nuclear Medicine and Molecular Imaging, 2022
- High fibroblast-activation-protein expression in castration-resistant prostate cancer supports the use of FAPI-molecular theranosticsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2021
- Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate CancerEuropean Urology, 2019